SEC Form 3 · accession 0001493152-18-005895
PetLife Pharmaceuticals, Inc. · PTLF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
De Leon Castro Laura
Officer — CEO/President/CFO · Director
Period of report
Mar 22, 2018
Accepted (ET)
Apr 27, 2018 · 7:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001354591
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.